Canada markets open in 6 hours 41 minutes

Canntab Therapeutics Limited (TBF1.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.5100+0.0280 (+5.81%)
As of 8:00AM CEST. Market open.
Full screen
Previous Close0.4820
Open0.5100
Bid0.5100 x 0
Ask0.5350 x 0
Day's Range0.5100 - 0.5100
52 Week Range0.3280 - 0.7250
Volume500
Avg. Volume17
Market Cap18.849M
Beta (5Y Monthly)1.28
PE Ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Canntab Announces the Early Exercise of $1,259,250 Warrants
    CNW Group

    Canntab Announces the Early Exercise of $1,259,250 Warrants

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce the receipt of C$1,259,250 in gross proceeds from the early exercise of 1,679,000 warrants into common shares (the "Warrants"). The Warrants were issued in the final week of May and each Warrant was exercised into 1 common share in the capital of the Company at $0.75. T

  • Canntab Mourns the Loss of Co-Founder
    CNW Group

    Canntab Mourns the Loss of Co-Founder

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announces, with very heavy hearts, the passing of Jeffrey Ward Renwick, the Company's Co-Founder, Director and President. After a long and difficult 15 month battle, Jeff succumbed to his lung cancer at the young age of 54 years.

  • Canntab Receives Export License Approval from Health Canada
    CNW Group

    Canntab Receives Export License Approval from Health Canada

    Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to announce that Health Canada has granted the company an Export License.